JP Morgan Maintains Overweight on Imax, Raises Price Target to $58
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsPrice Target
JP Morgan analyst David Karnovsky maintains Imax (NYSE:IMAX) with a Overweight and raises the price target from $50 to $58.
JP Morgan analyst David Karnovsky maintains Imax (NYSE:IMAX) with a Overweight and raises the price target from $50 to $58.